GSK-101468/196

Study Sponsor: GSK

Study Title

101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164

Medicine or Vaccine (generic name)

ropinirole

Sponsor Identification Number

101468/196

Trial Registry Identification Number(#'s)

NCT00650104

Medical Condition

Parkinson Disease

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=101468/196

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00650104

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 101468/164 and 101468/167.

Date Added to this Site

June 2014